Despite efforts to address racial disparities related to cancer, Black Americans are more likely to die from cancer than most other groups. New research suggests that a partial explanation may be higher rates of frailty ...
Apr 11, 2022
0
26
A research team led by Prof. Liu Qingsong and Liu Jing from the Hefei Institutes of Physical Science (HFIPS) of the Chinese Academy of Sciences (CAS) has recently found that nintedanib, a multikinase inhibitor of the receptor ...
Apr 7, 2022
0
30
Patients with pediatric-onset inflammatory bowel disease (IBD) may have an increased risk for developing cancer, particularly gastrointestinal cancers, according to a meta-analysis published online March 1 in JAMA Network ...
Mar 11, 2022
0
4
Gastrointestinal cancers are some of the most commonly diagnosed cancers, and they continue to be associated with poor survival outcomes. The drug adagrasib specifically targets the KRASG12C gene mutation that is common in ...
Feb 11, 2022
0
2
Rising numbers of young men and women aged under 50 suffering from gastrointestinal cancers—as reflected in a new study in South Australia—is worrying international experts.
Jan 31, 2022
0
7
A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital.
Jul 28, 2021
0
290
Doctors and patients are being advised to reduce unnecessary antibiotic use following new data suggesting that these medicines may increase the risk of cancer of the large intestine (colon), especially in people under 50 ...
Jul 2, 2021
0
4
Many people don't realize that the trillions of bacteria, viruses, and fungi residing within the gastrointestinal tract—collectively called the gut microbiome—are connected to overall health, and specifically to cancer.
Jun 24, 2021
0
15
LMU researchers have identified the 14-3-3sigma gene as an important suppressor of carcinogenesis in the gastrointestinal tract.
Jun 16, 2021
0
1
A study by Mayo Clinic researchers provides some clarity in the use of direct oral anticoagulants (DOAC), such as apixaban and rivaroxaban, to treat acute venous thromboembolism (VTE) in patients with gastrointestinal cancers. ...
Jun 4, 2021
0
1
